道恩股份(002838.SZ):公司現有TPV產能4萬噸,在建產能5萬噸
格隆匯7月10日丨道恩股份(002838.SZ)在投資者互動平台表示,公司研發出國內第一條擁有自主知識產權的TPV生產線,打破TPV行業國際技術壟斷,被授予“國家科學技術獎技術發明二等獎”的榮譽,引領熱塑性彈性體TPV行業的發展。公司生產的TPV是一類替代傳統橡膠的新型高分子材料,是傳統橡膠的升級品種,是一種石油節約型、能源節約型的可持續發展的“綠色”高分子材料,可以替代傳統橡膠,解決橡膠工業“黑色污染”和“難回收”的問題。TPV廣泛應用於汽車領域,軌道交通、潔淨水管、運動休閒場所等領域。公司現有TPV產能4萬噸,在建產能5萬噸。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.